Andrey Vladimirovich Zadorozhniy

Andrey Vladimirovich Zadorozhniy

Auto-generated profile, based on publicly available information

Andrey Vladimirovich Zadorozhniy

Rostov State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2024 in Clinical Dentistry (Russia)
Verified
Journal Article
Open access
PDF file
DMDenis Moiseev
Denis Moiseev
АХА.в. Хейгетян
А.в. Хейгетян
МКМ.р. Караммаева
М.р. Караммаева
АЗА.в. Задорожний
А.в. Задорожний
МЗМ.а. Задорожний
М.а. Задорожний
ДФД.в. Феоктистова
Д.в. Феоктистова
Быстропрогрессирующий пародонтит как форма агрессивного течения пародонтита характеризуется выраженной потерей клинического прикрепления и деструкцией альвеолярной кости с ранней манифестацией у системно здоровых людей. Эффективность лечения такого заболевания невысокая, связана в том числе с уровнем приверженности пациента лечению, со сроками начала терапии и особенностью иммунной системы больного. Цель исследования — повысить эффективность лечения быстропрогрессирующего пародонтита путем включения в комплексную терапию новой методики интрапериопокетного гальванофореза c гидроксидом меди—кальция. Был оценен стоматологический (включая пародонтальный) статус, определены индекс зубной бляшки по Силнесс—Лоу, индекс кровоточивости десны при зондировании (BoP), папиллярно-маргинально-альвеолярный индекс (PMA), проведена периотестометрия с помощью прибора Periotest S. Состояние твердых тканей зубов и пульпы определяли с помощью вертикальной перкуссии, зондирования и электроодонтодиагностики (ЭОД) с помощью прибора ПульпЭст L (Геософт, Россия—Израиль). Методику интрапериопо´кетного гальванофореза проводили с препаратом гидроксида меди—кальция Купрал (HumanChemie, Германия) и полоской алюминиевой фольги, которую фиксировали медицинским клеем «Сульфакрилат» (НТО «Медицинские Инновации», Россия). Для обтурации отверстий дентинных канальцев и реминерализации дентина использовали Дентин-герметизирующий ликвид (HumanChemie, Германия). На 14-е сутки от начала лечения фиксировали купирование воспалительного процесса в тканях пародонта и уменьшение количества зубного налета по всем оцениваемым показателям. Динамика показателей ЭОД: в области зубочелюстных сегментов основной группы значения показателей увеличились через 6 месяцев после лечения в 1,7—3,5 раза. В области зубочелюстных сегментов группы сравнения значения ЭОД через 6 месяцев как увеличивались, так и уменьшались, от 1,3 до 2 раз по сравнению с исходными значениями. Проведенная терапия быстропрогрессирующего пародонтита с применением новой методики интрапериопо´кетного гальванофореза гидроксидом меди—кальция и глубоким фторированием дентина корней зубов в представленном клиническом случае показала свое преимущество перед традиционным лечением, является перспективной и может повысить эффективность лечения и свести к минимуму частоту рецидивов быстропрогрессирующего пародонтита. Rapidly progressive periodontitis, as a form of aggressive periodontitis, is characterized by a pronounced loss of clinical attachment and destruction of the alveolar bone with early manifestation in systemically healthy people. The effectiveness of treatment of such a disease is low, it is associated, among other things, with the level of patient’s adherence to treatment, with the timing of the start of therapy and the peculiarity of the patient’s immune system. The aim of the study was to increase the effectiveness of the treatment of rapidly progressive periodontitis by including in complex therapy a new technique of intraperiopoket galvanophoresis with copper—calcium hydroxide. . The dental (including periodontal) status was assessed, the Silness—Low dental plaque index, the gingival bleeding index during probing (BoP), the papillary-marginal-alveolar index (PMA) were determined, and periotestometry was performed using the Periodest S device. The condition of the hard tissues of teeth and pulp was determined using vertical percussion, probing and electro-dental diagnostics (EDI) using the Pulpest L device (Geosoft, Russia—Israel). The intraperiopocket galvanophoresis procedure was performed with Cupral copper—calcium hydroxide preparation (HumanChemie, Germany) and a strip of aluminum foil, which was fixed with Sulfacrylate medical glue (NTO “Medical Innovations”, Russia). Dentin-sealing liquid (HumanChemie, Germany) was used to obstruct the openings of the dentine tubules and ensure the remineralization of dentin. . On the 14th day from the beginning of treatment, the relief of...

30 January 2024 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
OSOlga V. Shelemekh
Olga V. Shelemekh
VPViktor L. Popkov
Viktor L. Popkov
AZAndrey V. Zadorozhniy
Andrey V. Zadorozhniy
INIrina B. Nektarevskaya
Irina B. Nektarevskaya
NKNikolay E. Korovaykin
Nikolay E. Korovaykin
Introduction: Although nonsteroidal anti-inflammatory drugs (NSAIDs) have a clear therapeutic benefit, they can also have serious side effects. The most serious of these is the ulcerogenic effect, which can result in a decline in the quality of life or even death. This calls for the search for and creation of novel compounds with potent anti-inflammatory properties that do not have adverse effects on the digestive system. The aim of the study was to investigate the anti-inflammatory, analgesic, ulcerogenic and anti-ulcerogenic activities of N-isopropenylimidazole zinc complex derivative. Materials and Methods: Experiments in rats and mice were used to determine the median lethal dose LD50 for N-isopropenylimidazole zinc complex derivative (laboratory name Pilim-1). Experimental models of acute exudative inflammation and chronic proliferative inflammation were used. In the first case, the inflammation was induced by sub-plantar injection of carrageenan and a complete Freund’s adjuvant into the hind paw of rats. In the second case, the inflammation was induced by the implantation of a sterile cotton pellet (“cotton pellet–induced granuloma”) under the skin of rats. Acute and tonic pain, visceral, and somatic deep pain were simulated using the formalin test in rats and the acetic acid-induced writhing test in mice, respectively. The ulcerogenic and anti-ulcerogenic effects of Pilim-1 were studied in rat experiments. Pilim-1 and the reference drugs diclofenac, indomethacin and famotidine were administered intragastrically. Results and Discussion: Pilim-1 showed marked anti-inflammatory and analgesic effects, demonstrated less toxicity than diclofenac and indomethacin, while its activity is comparable to diclofenac and superior to indomethacin. Its therapeutic index is higher than that of indomethacin and diclofenac and, in contrast, it essentially has no ulcerogenic effect and exhibits stronger anti-ulcerogenic activity than famotidine. It appears that the anti-inflammatory, analgesic, and gastroprotective properties of Pilim-1 are largely due to its antioxidant and antihypoxic properties, its inhibitory effects on cyclooxygenase and 5-lipoxygenase, and the presence of imidazole and zinc in its structure, both of which have a wide range of biological activity. Conclusion: Pilim-1 can be recommended for further preclinical studies due to its relatively low (practically absent) ulcerative activity, strong anti-inflammatory, analgesic, and anti-ulcerative effects, greater therapeutic index, and less acute toxicity in comparison with diclofenac and indomethacin.

18 July 2024 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
ITIvan Y Torshin
Ivan Y Torshin
AGAndrey N. Gromov
Andrey N. Gromov
IRIvan A. Reyer
Ivan A. Reyer
OGOlga Gromova
Olga Gromova
AZAnait Zelenskaya
Anait Zelenskaya
Introduction: For effective and safe pharmacotherapy of pain, it is important to evaluate the mechanisms and spectrum of action of non-steroidal anti-inflammatory drugs (NSAIDs), including their effect on the proteom, central effect, as well as pain relieving and anti-inflammatory effects. The aim of the study was to evaluate the complex of differences between the promising candidate-molecule of indole derivative SV-1010 and the well-known NSAIDs. Materials and Methods: Chemoproteomic moduling of pharmacological effects of SV-1010 and NSAID diclofenac, nimesulide and ketorolac on the rat proteom by means of topological analysis of chemographs. Results: The significant differences in the effects of the studied molecules were found for 820 proteins of the rat proteom. SV-1010, to a lesser degree than the other molecules, can inhibit dopamine D1- and D2-type receptors and, at the same time, stimulate the release of dopamine in the neostriatum (EC50 = 27 nM). SV-1010, to a greater extent than the other molecules, can inhibit the GABA conveyor (EC50 = 65 nM) and the NMDA receptors Grin1/Grin2b (IC50 175 nM). SV-1010 can activate Cannabinoid CB2 receptors, inhibit enzymes of leukotriene biosynthesis, CC receptors of pro-inflammatory chemokines and leukotrienes. Conclusion: The chemoreactomic and chemoproteomic profiling of SV-1010 indicated its potential central effect through dopaminergic and GABA-neurotransmission and additional anti-inflammatory mechanisms, which can help increase pain-relieving effects.

19 February 2025 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
ASAlina Sergeeva
Alina Sergeeva
ITIvan Y Torshin
Ivan Y Torshin
AGA. N. Gromov
A. N. Gromov
IRI. A. Reyer
I. A. Reyer
ISI. V. Sholl
I. V. Sholl
Background. Nonsteroidal anti-inflammatory drugs (NSAIDs) are used for effective and safe pharmacotherapy of inflammation and pain. NSAIDs usually reduce the level of gastroprotective prostaglandin E2 due to cyclooxygenase-1 inhibition. The zinc-containing candidate molecule N-allylimidazole-zinc (bis-(N-allylimidazole) zinc diacetate) is a promising anti-inflammatory drug, potentially devoid of gastrotoxicity.Objective: chemoreactome modeling of the pharmacological effects of N-allylimidazole-zinc and zinc derivatives of known NSAIDs (diclofenac, nimesulide, ketorolac) using topological analysis of chemographs of numerical prediction in complex feature systems.Material and methods. In silico modeling of the candidate molecule N-allylimidazole-zinc synthesized at Federal Research Center “Favorsky Irkutsk Institute of Chemistry” (Siberian Branch of Russian Academy of Sciences), was carried out using a conglomerate of chemoinformatic molecule analysis methods of Yu.I. Zhuravlev scientific school. These methods include the theory of chemograph analysis, methods for predicting numerical target variables, combinatorial theory of solvability/regularity, topological data analysis. Chemoreactome, pharmacoinformation and chemoneurocytological methods of analyzing the molecules properties are based on chemoreactome methodology, the latest direction in the application of machine learning systems in the field of postgenomic pharmacology. The pharmacological capabilities of molecules within chemoreactome methodology are assessed by comparing the chemical structure of racetam molecules with the structures of molecules for which the molecular pharmacological properties have been studied using artificial intelligence learning algorithms based on big data information presented in PubChem, HMDB, STRING, PharmGKB databases. Based on the entire complex of differences between molecules in interactions with receptor proteins, the “anti-obesity” score was calculated for each as the serial number of this molecule when sorting in descending order the values of the corresponding chemoreactome constants.Results. It was shown that N-allylimidazole-zinc may have anti-inflammatory effect due to the influence on cytokine activity and, in part, on prostaglandin and leuktriene metabolism. Its central effects are comparable to the effects of zinc-NSAIDs. The analgesic potential of N-allylimidazole-zinc may be associated with the inhibition of kinin receptors, weak antihistaminic and antinociceptive properties. The molecule may exhibit a protective effect on epithelial gastric mucosa and does not impair the properties of the stomach mucosal protective layer. It has been shown that N-allylimidazole-zinc, compared to other compounds included in the analysis, has the least negative effect on the metabolism of various vitamins and microelements.Conclusion. Chemoreactome profiling of N-allylimidazole-zinc indicates the prospects for its use as an anti-inflammatory drug.

20 February 2024 in Russian Journal of Operative Surgery and Clinical Anatomy
Verified
Journal Article
Closed access
Hadi Majed Soud DarawshehHadi Majed Soud Darawsheh
Hadi Majed Soud Darawsheh
APA.M. Panin
A.M. Panin
APA.V. Pavlov
A.V. Pavlov
NTN.V. Tiunova
N.V. Tiunova
EKE.YU. Kanukoeva
E.YU. Kanukoeva
AZA.V. Zadorozhny
A.V. Zadorozhny
Background. Anesthesia of the structures innervated by the mandibular nerve is necessary to provide adequate pain relief during dental and local surgical interventions. Local anesthesia on the lower jaw is difficult to carry out, this is due to anatomical variations in the structure of the facial skeleton, so studying the anatomical features of the pterygomandibular space is an urgent task. Objective. Study of the anatomical features of the pterygomandibular space. Material and methods. The material for the study was 46 heads of adult corpses. We determined the volume of the pterygomandibular space using silicone injection depending on the cranial indices. Conclusions. According to the results of the correlation analysis, statistically significant positive correlations of the cranial index with the width of the pterygomandibular space on the right, as well as the length and width on the left, were revealed. Statistically significant positive correlations of the cranial index with the width of the pterygomandibular space on the right, as well as the length and width on the left, were revealed.

30 March 2022 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
TVTseluiko Kristina V.
Tseluiko Kristina V.
VLValeriy K. Leontev
Valeriy K. Leontev
MZMark A. Zadorozhniy
Mark A. Zadorozhniy
VPViktor L. Popkov
Viktor L. Popkov
SMSonya V. Meladze
Sonya V. Meladze
Introduction: Insufficient effectiveness of traditional drug therapy in a treatment of patients with chronic generalized periodontitis, as well as high social significance of this problem, determines the need to search for new drugs and their compositions aimed at solving it. Aim of the study: To increase the efficacy of complex treatment of periodontitis with the administration of Soder­m®-Forte gel and a new injectable form of Rexod®. Materials and methods: Experiments were performed in 50 male Wistar rats. Experimental periodontitis (EP) was simulated by ligation of the necks of lower incisors. We studied the animals with intact periodontium, untreated EP, and when traditional drug therapy (TDT), as well as the combinations of TDT with Soderm®-Forte gel and additionally with the new injectable dosage form (NIF) of Rexod® were administered. The general condition, behavior, nutrition and body weight of the animals were evaluated. The Schiller-Pisarev test and the Muhlemann-Cowell bleeding index were used, and the amount of crevicular fluid (CF) was measured. The contamination of the marginal gum with microorganisms was determined. Results and discussion: The TDT in EP has a moderate therapeutic effect, which does not lead to a sufficiently high pharmacotherapeutic effect, whereas the combinations of TDT with Soderm®-Forte and, to a greater extent, TDT with Soderm®-Forte and NIF of Rexod® have high therapeutic efficacy, which is statistically confirmed by a sharp decrease in the amount of CF, the Schiller-Pisarev test and the Muhlemann-Cowell bleeding index, as well as absolute suppres­sion of pathogenic microorganisms. Conclusion: The combinations of TDT with Soderm®-Forte gel and NIF of Rexod® in EP in rats can significant­ly increase the effectiveness of the treatment. The data obtained indicate the expediency of the administration of Soderm®-Forte gel, as well as its combination with NIF of Rexod® in dental practice in the complex therapy of patients with periodontitis.